FDA-approvedpeptide drugs Peptide-based drugs represent a significant advancement in modern medicine, offering a versatile and highly targeted approach to treating a wide range of diseases.作者：B Zheng·2025·被引用次数：28—As of 2023,over 80 peptide drugs have gained global approval, with more than 200 peptides in clinical development, focusing on infectious diseases, autoimmune ... These therapeutic agents, composed of short chains of amino acids linked by peptide bonds, are increasingly recognized for their superior biocompatibility and excellent specificity. With over 80 peptide drugs already gaining global approval and many more in clinical development, peptide-based therapeutics are becoming a powerful frontier in medical innovation, providing effective solutions for challenging conditions and paving the way for personalized medicine.
At their core, peptide-based drugs are molecules derived from peptides, which are naturally occurring or synthetically created chains of amino acids.Zealand Pharma is a biotechnology company dedicated todeveloping innovative peptide-based medicinesfor people living with unmet medical needs. These chains can vary in length, but therapeutic peptides typically range from a few amino acids to several dozen'People are turning themselves into lab rats': the injectable .... Unlike small molecule drugs, peptides often mimic the body's own signaling molecules, such as hormones and growth factors, allowing them to interact with specific biological targets with high precision. This inherent specificity is a key reason for their growing prominence in drug development.
The development of peptide-based drugs has seen remarkable progress, driven by advances in synthesis, delivery systems, and a deeper understanding of biological pathways. Companies are developing innovative platforms for the discovery of peptide-based modalities, aiming to create novel treatments for unmet medical needs. This includes exploring their potential in areas like immunotherapy, where peptides can be designed as vaccines or immunological modulators.2024年2月15日—Peptide Drugs ·Abarelix (Plenaxis) and Degarelix (Firmagon) for advanced prostate cancer · Carfilzomib (Kyprolis) for multiple myeloma ...
The therapeutic applications of peptide-based drugs are incredibly diverse, reflecting their ability to perform a variety of biological functions. They can act as hormones, growth factors, neurotransmitters, or ligands for ion channels, directly influencing cellular processes. This versatility makes them suitable for treating conditions ranging from diabetes and metabolic disorders to cancer and autoimmune diseases.
For instance, well-known peptide drugs like insulin are essential for managing diabetes. More recent advancements have introduced GLP-1 medications such as Ozempic and Wegovy, which have gained significant attention for their role in weight management and type 2 diabetes treatment.'People are turning themselves into lab rats': the injectable ... These drugs, exemplified by semaglutide and tirzepatide, highlight the growing impact of peptide therapeutics in chronic disease management. Other examples include Abarelix and Degarelix for advanced prostate cancer, and Carfilzomib for multiple myeloma, showcasing their utility in oncology.Therapeutic Peptides: Recent Advances in Discovery ...
Beyond direct therapeutic action, peptide-based drug delivery systems are also a critical area of research. These systems leverage peptide-based carriers to enhance drug stability, improve bioavailability, and target specific tissues or cells, such as delivering cytotoxic agents directly to cancer cells to improve efficacy and minimize side effects作者：DJ Craik·2013·被引用次数：2510—This article uses selected examples ofpeptidesto highlight the importance ofpeptide drugs, some potential new opportunities for their exploitation,.
Peptide-based drugs offer several distinct advantages. Their high target affinity means they can bind more effectively to their intended biological targets, leading to greater therapeutic efficacy.What are peptides? | Definition & Examples - Bachem Furthermore, they generally exhibit high safety profiles due to their inherent biocompatibility and ability to be broken down by natural biological processes, primarily proteolytic degradation.
However, the development of peptide-based drugs also presents challenges. Their relatively large size compared to small molecules can affect their absorption and distribution within the body, often necessitating alternative delivery methods like injectionsBreakthroughs in innovative peptide therapeutics. Stability can also be an issue, as peptides are susceptible to degradation by enzymes in the body. Overcoming these hurdles requires sophisticated drug delivery platforms and innovative formulation strategies.
The future of peptide-based drugs appears exceptionally bright. Ongoing research and development are continuously expanding the scope of their applications. The integration of artificial intelligence, for example, is accelerating the discovery of novel peptides and predicting their binding affinities, streamlining the drug development process. As our understanding of molecular biology deepens and technological capabilities advance, peptide therapeutics are poised to play an even more critical role in addressing complex diseases and improving patient outcomes.'People are turning themselves into lab rats': the injectable ... The journey of peptide-based drugs from laboratory discovery to clinical application is a testament to their transformative potential in the pharmaceutical landscape.
Join the newsletter to receive news, updates, new products and freebies in your inbox.